Skip to main content

Advertisement

Table 2 Selected miRNAs and their alterations pre- and post-operation in case and control groups

From: Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules

  Median Mean ± SD P-value
miR-222 PTC Pre-op 23.82 23.85 ± 1.88 < 0.001
Post-op 27.28 27.47 ± 1.67
Control Pre-op 30.28 30.66 ± 2.85 0.61
Post-op 31.25 31.04 ± 2.51
miR-181a PTC Pre-op 29.27 29.06 ± 1.70 < 0.001
Post-op 33.53 33.60 ± 1.75
Control Pre-op 36.79 38.57 ± 4.97 0.06
Post-op 40.20 40.99 ± 5.64
miR-155-5p PTC Pre-op 36.69 38.29 ± 4.37 < 0.001
Post-op 36.91 38.49 ± 4.48
Control Pre-op 36.78 37.93 ± 4.30 < 0.001
Post-op 36.93 38.18 ± 4.28
miR-146a PTC Pre-op 26.36 26.53 ± 1.61 < 0.001
Post-op 29.13 28.89 ± 1.82
Control Pre-op 31.25 31.41 ± 2.80 < 0.001
Post-op 33.75 33.52 ± 2.39
  1. The data regarding miRs are presented here both by median and mean±SD, while the P-values depict the difference of distinct miRs within PTC or control groups (P-values were determined by independent samples t-test)